Radiolabeled Nanomaterial for Cancer Diagnostics and Therapeutics: Principles and Concepts

Overview

Journal Cancer Nanotechnol

Specialty Biotechnology

Date 2023 Mar 3

PMID 36865684

Authors

Muskan Goel

Yuri Mackeyev

Sunil Krishnan

Affiliations

Soon will be listed here.

Abstract

In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora of applications in biology and medicine. A convergence of these disciplines has emerged more recently with the advent of nanotechnology-aided radiopharmaceuticals. Capitalizing on the unique physical and functional properties of nanoparticles, radiolabeled nanomaterials or nano-radiopharmaceuticals have the potential to enhance imaging and therapy of human diseases. This article provides an overview of various radionuclides used in diagnostic, therapeutic, and theranostic applications, radionuclide production through different techniques, conventional radionuclide delivery systems, and advancements in the delivery systems for nanomaterials. The review also provides insights into fundamental concepts necessary to improve currently available radionuclide agents and formulate new nano-radiopharmaceuticals.

Citing Articles

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions.

Alkatheeri A, Salih S, Kamil N, Alnuaimi S, Abuzar M, Abdelrahman S Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006069 PMC: 11859487. DOI: 10.3390/ph18020257.

Recent Advancements of Nanomedicine in Breast Cancer Surgery.

Meng X, Wang X, Zhang Z, Song L, Chen J Int J Nanomedicine. 2025; 19():14143-14169.

PMID: 39759962 PMC: 11699852. DOI: 10.2147/IJN.S494364.

Harnessing Radiation for Nanotechnology: A Comprehensive Review of Techniques, Innovations, and Application.

Islam M, Ahmed M, Yun S, Kim H, Nam K Nanomaterials (Basel). 2024; 14(24).

PMID: 39728587 PMC: 11676052. DOI: 10.3390/nano14242051.

Recent Advances in Metal Oxide and Phosphate Nanomaterials Radiolabeling with Medicinal Nuclides.

Janska T, Sakmar M, Stibr M, Vlk M, Kozempel J ACS Omega. 2024; 9(38):39297-39306.

PMID: 39346817 PMC: 11425600. DOI: 10.1021/acsomega.4c04145.

Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer.

Andrew J, Ezra-Manicum A, Witika B EJNMMI Radiopharm Chem. 2024; 9(1):62.

PMID: 39180599 PMC: 11344754. DOI: 10.1186/s41181-024-00295-7.

References

Hu H, Huang P, Weiss O, Yan X, Yue X, Zhang M . PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters. Biomaterials. 2014; 35(37):9868-9876. PMC: 4180787. DOI: 10.1016/j.biomaterials.2014.08.038. View

Katifelis H, Mukha I, Bouziotis P, Vityuk N, Tsoukalas C, Lazaris A . Ag/Au Bimetallic Nanoparticles Inhibit Tumor Growth and Prevent Metastasis in a Mouse Model. Int J Nanomedicine. 2020; 15:6019-6032. PMC: 7429210. DOI: 10.2147/IJN.S251760. View

Michalet X, Pinaud F, Bentolila L, Tsay J, Doose S, Li J . Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005; 307(5709):538-44. PMC: 1201471. DOI: 10.1126/science.1104274. View

Steen E, Jorgensen J, Johann K, Norregaard K, Sohr B, Svatunek D . -Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging. ACS Nano. 2019; 14(1):568-584. PMC: 7075664. DOI: 10.1021/acsnano.9b06905. View

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

Kumar R, Roy I, Ohulchanskyy T, Goswami L, Bonoiu A, Bergey E . Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano. 2009; 2(3):449-56. DOI: 10.1021/nn700370b. View

Kim J, Porte Y, Ko K, Kim H, Myoung J . Micropatternable Double-Faced ZnO Nanoflowers for Flexible Gas Sensor. ACS Appl Mater Interfaces. 2017; 9(38):32876-32886. DOI: 10.1021/acsami.7b09251. View

Kim D, Park S, Lee J, Jeong Y, Jon S . Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2007; 129(24):7661-5. DOI: 10.1021/ja071471p. View

Garg I, Nathan M, Packard A, Kwon E, Larson N, Lowe V . C-choline positron emission tomography/computed tomography for detection of disease relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen ≤0.1 ng/ml. J Cancer Res Ther. 2020; 17(2):358-365. DOI: 10.4103/jcrt.JCRT_373_19. View

10.

Fan Q, Cheng K, Hu X, Ma X, Zhang R, Yang M . Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc. 2014; 136(43):15185-94. PMC: 4227813. DOI: 10.1021/ja505412p. View

11.

El-Marakby E, Hathout R, Taha I, Mansour S, Mortada N . A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with glycyrrhizin. Int J Pharm. 2017; 525(1):123-138. DOI: 10.1016/j.ijpharm.2017.03.081. View

12.

Min Y, Caster J, Eblan M, Wang A . Clinical Translation of Nanomedicine. Chem Rev. 2015; 115(19):11147-90. PMC: 4607605. DOI: 10.1021/acs.chemrev.5b00116. View

13.

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

14.

Zhang Q, Han L, Jing H, Blom D, Lin Y, Xin H . Facet Control of Gold Nanorods. ACS Nano. 2016; 10(2):2960-74. DOI: 10.1021/acsnano.6b00258. View

15.

Yang K, Hu L, Ma X, Ye S, Cheng L, Shi X . Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater. 2012; 24(14):1868-72. DOI: 10.1002/adma.201104964. View

16.

Leu A, Berk D, Lymboussaki A, Alitalo K, Jain R . Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 2000; 60(16):4324-7. View

17.

Marin A, Martin M, Linan O, Alvarenga F, Lopez M, Fernandez L . Bystander effects and radiotherapy. Rep Pract Oncol Radiother. 2014; 20(1):12-21. PMC: 4268598. DOI: 10.1016/j.rpor.2014.08.004. View

18.

Zhou J, Yu M, Sun Y, Zhang X, Zhu X, Wu Z . Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials. 2010; 32(4):1148-56. DOI: 10.1016/j.biomaterials.2010.09.071. View

19.

Chen S, Yang K, Tuguntaev R, Mozhi A, Zhang J, Wang P . Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2015; 12(2):269-86. PMC: 4789173. DOI: 10.1016/j.nano.2015.10.020. View

20.

Zhang X, Yao M, Chen M, Li L, Dong C, Hou Y . Hyaluronic Acid-Coated Silver Nanoparticles As a Nanoplatform for in Vivo Imaging Applications. ACS Appl Mater Interfaces. 2016; 8(39):25650-25653. DOI: 10.1021/acsami.6b08166. View